Long-Term Outcomes of Endoscopic-assisted vs Conventional Breast-conserving Surgery in Breast Cancer Patients After Neoadjuvant Therapy: a Randomized, Multicenter, Open Label, Non-inferiority Trial

With the title of "Long-Term Outcomes of endoscopic-assisted vs conventional breast-conserving surgery in breast cancer patients after neoadjuvant therapy: a randomized, multicenter, open label, non-inferiority trial", this study targets breast cancer patients after neoadjuvant therapy. A total of 804 eligible patients, after screening with inclusion and exclusion criteria, will be randomly assigned to Endoscopic-assisted breast conserving surgery(E-BCS) or conventional breast conserving surgery (C-BCS) group at a 1:1 ratio using stratified block randomization method, stratified by centers and

Trial Details

NCT ID

NCT06716073

Phase

NA

Sponsor

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Status

RECRUITING

Cancer Type

Breast Cancer

Interventions

• Surgery

Locations (sample)

• Guangzhou, Guangdong, China|23.11667,113.25
• Shantou, Guangdong, China|23.35489,116.67876

Key Eligibility Criteria

• Age ranging from 18 to 75 years
• Pathologically confirmed invasive breast cancer
• Receiving preoperative chemotherapy (Each molecular subtype corresponds to unanimous regimen)
• cT1-3N0-3M0

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Breast Cancer Trials on Trialify →